Aptadir Therapeutics

Seed
aptadir.com Biotech & Healthcare Milan, Italy
Total Funding $45M
Latest Round $45M Seed
Last Announced Sep 29, 2026
Investors 11 Backers
Decision Makers 1 Verified

About Aptadir Therapeutics

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Milan, Italy
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website aptadir.com
Domain Registered Date Feb 13, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $45,000,000 · Seed

    entarabi.com

  2. Milestone

    Website domain registered

    aptadir.com

Investors & Backers

11
4BIO Capital
Angelini Ventures
CDP Venture Capital
Club degli Investitori
Crescent Enterprises
Evotec
Extend
Indaco Venture Partners
Italian Angels for Biotech
Kerna Ventures
XGEN Venture

Funding History

1 Round
Seed · Sep 29, 2026
$45,000,000 entarabi.com

Founders & Leadership

5

Annalisa Di Ruscio

Founder

Work email & phone locked Unlock →

Daniel G. Tenen

Founder

Work email & phone locked Unlock →

Giovanni Amabile

CEO & Executive Chairman

Work email & phone locked Unlock →

Marcin Kortylewski

Founder

Work email & phone locked Unlock →

Vittorio de Franciscis

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts